VIVALDI Praxis: Valdoxan improves depressive symptoms and normalizes circadian rhythms: A prospective multicentre observational study.

Trial Profile

VIVALDI Praxis: Valdoxan improves depressive symptoms and normalizes circadian rhythms: A prospective multicentre observational study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2013

At a glance

  • Drugs Agomelatine (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms VIVALDI-Praxis
  • Sponsors Servier
  • Most Recent Events

    • 30 Sep 2010 Actual end date (30 Sep 2010) added as reported by ISRCTN: Current Controlled Trials.
    • 30 Sep 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 26 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top